Literature DB >> 20033826

Relationship between lectin-like oxidized low-density lipoprotein receptor 1 expression and preoperative echogenic findings of vulnerable carotid plaque.

Atsushi Saito1, Miki Fujimura, Takashi Inoue, Hiroaki Shimizu, Teiji Tominaga.   

Abstract

PURPOSE: Lectin-like oxidized low-density lipoprotein 1 (LOX1) is an important cell surface receptor for the progression of atherosclerosis. Our purpose is to clarify the relationships of LOX1 and atherosclerotic factors for the vulnerability of carotid plaque and preoperative echogenic findings.
METHODS: We examined LOX1 expression, matrix metalloproteinase (MMP)-2,9, and tissue inhibitor of MMP (TIMP)-2 by immunohistochemical analysis using carotid endarterectomy specimens obtained from 14 patients. Groups were divided into stable plaque group A and vulnerable plaque group B by preoperative echogenic findings of carotid plaques. Endothelial immunoreactivity was calculated, and the immunohistochemical findings were compared.
RESULTS: LOX1 was remarkably expressed, especially in smooth muscle cells in vulnerable plaque and colocalized in MMP-9 positive cells and apoptotic cells. All LOX1, MMP-2,9, and TIMP2 were remarkably expressed in the subendothelial layer in group B compared with group A. The endothelial LOX1 index was 63.75 +/- 4.92 in group A and 83.0 +/- 5.02 in group B (p = 0.02). The endothelial MMP-2 index was 24.38 +/- 5.50 in group A and 32.83 +/- 6.79 in group B (p = 0.01). The endothelial MMP-9 index was 46.13 +/- 6.31 in group A and 59.17 +/- 2.14 in group B (p = 0.002). The endothelial TIMP-2 index had no significant difference between two groups (p = 0.14).
CONCLUSION: LOX-1 may play an important role in the progression of vulnerable carotid plaque and might regulate vulnerable plaque formation in cooperation with MMPs and TIMP-2. Endothelial MMP-2 might suppress TIMP-2 activation in vulnerable plaques.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033826     DOI: 10.1007/s00701-009-0573-1

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.

Authors:  Jens De Vos; Iris Mathijs; Catarina Xavier; Sam Massa; Ulrich Wernery; Luc Bouwens; Tony Lahoutte; Serge Muyldermans; Nick Devoogdt
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

2.  Expression of transforming growth factor beta 1-related signaling proteins in irradiated vessels.

Authors:  Raimund H M Preidl; Patrick Möbius; Manuel Weber; Kerstin Amann; Friedrich W Neukam; Andreas Schlegel; Falk Wehrhan
Journal:  Strahlenther Onkol       Date:  2014-12-09       Impact factor: 3.621

3.  Association of oxysterol binding protein-related protein 9 polymorphism with cerebral infarction in Hunan Han population.

Authors:  Lingjuan Li; Geyue Qu; Mingyue Wang; Qing Huang; Yunhai Liu
Journal:  Ir J Med Sci       Date:  2013-11-05       Impact factor: 1.568

4.  Association between carotid plaque and Parkinson's disease.

Authors:  Lan-Yun Yan; Qing-Fang He; Min-Yan Lu; Sheng-Long Wang; Zhi-Qiang Qi; Hai-Rong Dong
Journal:  Ann Transl Med       Date:  2019-03

5.  Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.

Authors:  Chiharu Yokoyama; Takuma Aoyama; Takahiro Ido; Akemi Kakino; Takeru Shiraki; Toshiki Tanaka; Kazuhiko Nishigaki; Aiko Hasegawa; Yoshiko Fujita; Tatsuya Sawamura; Shinya Minatoguchi
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

6.  Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells.

Authors:  Magda Gioia; Giulia Vindigni; Barbara Testa; Sofia Raniolo; Giovanni Francesco Fasciglione; Massimiliano Coletta; Silvia Biocca
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.